Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qijiaoshengbai Capsules for leukopenia
ChiCTR-IPR-15006758Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jan 2015
- Countries
- 1
01
Overview
Phase 4 trial of Qijiao Shengbai Jiaonang in leukopenia (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: White blood cell count and Neutrophil count. Planned start Jan 2015; status: not yet recruiting.
02
Drugs
Qijiao Shengbai Jiaonang
03
Conditions
leukopenia
Beyond the preview
Go deeper on ChiCTR-IPR-15006758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006758.